Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Bridging the Brain Disease Knowledge Gap Through Computational Modeling and Systems Biology
Vitamin D3 Receptor ( VDR ) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis.
Basis for fluctuations in lymphocyte counts in fingolimod-treated patients with multiple sclerosis.
Assessment of cerebral venous return by a novel plethysmography method.
Olive oil phenols and neuroprotection.
New data at ENS show Novartis drug Gilenya benefited patients by improving all four key measures of multiple sclerosis
Alemtuzumab (Lemtrada) - NICE says yes in final draft guidance
Transcriptomics: mRNA and alternative splicing.
[Cognitive impairment in demyelinating disease].
Biochemical Markers of Autoimmune Diseases of the Nervous System.
Quantitative assessment of multiple sclerosis using inertial sensors and the TUG test.
Glatiramer acetate-induced hepatitis in a young female patient with multiple sclerosis.
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation.
Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.
Multiple sclerosis: Does aggressive MS warrant aggressive treatment?
Frequency of obsessive-compulsive disorder in patients with multiple sclerosis: A cross-sectional study.
Evaluation of the 2010 McDonald multiple sclerosis criteria in children with a clinically isolated syndrome.
New Analysis Suggests Aubagio® (teriflunomide) Slows Brain Atrophy in People with Relapsing Multiple Sclerosis
A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
Long-term follow-up of vanishing tumors in the brain: How should a lesion mimicking primary CNS lymphoma be managed?
Chronic inflammatory demyelinating polyneuropathy following malignant melanoma.
Current Immune Therapies of Autoimmune Disease of the Nervous System with Special Emphasis to Multiple Sclerosis.
Active Biotech announce that European Medicines Agency accepts start of scientific review of the marketing authorization application for laquinimod in relapsing-remitting multiple sclerosis
PEGylated interferon beta-1a in the treatment of multiple sclerosis - an update.
Comparative efficacy of fingolimod vs natalizumab: A French multicenter observational study.
Pages
« first
‹ previous
…
152
153
154
155
156
157
158
159
160
…
next ›
last »